This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Rab Diagnostics as, Other. Active years: 2022-2026.
Company Filing History:
1 out of 1 
1 out of 834,411 Years Active: 2022-2026
Title: Innovations in Cancer Therapy by Olav Engebråten
Introduction
Olav Engebråten is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of cancer therapy through his innovative approaches and research. His work focuses on improving the diagnosis and treatment of cancer, which is a critical area of medical research.
Latest Patents
Olav Engebråten holds a patent related to the diagnosis and treatment of cancer. This invention encompasses compositions and methods for cancer therapy, particularly those that utilize cancer biomarkers. The patent emphasizes the prediction of a subject's response to various cancer therapies, which can greatly enhance treatment outcomes.
Career Highlights
Throughout his career, Olav has dedicated himself to advancing cancer treatment methodologies. His innovative ideas and research have positioned him as a key figure in the medical community, particularly in the realm of oncology.
Collaborations
Olav has worked alongside talented colleagues, including Anette Weyergang and Maria Eb Berstad. Their collaborative efforts have contributed to the development of effective cancer therapies and have fostered a productive research environment.
Conclusion
Olav Engebråten's work in cancer therapy exemplifies the impact of innovation in medicine. His patent and collaborative efforts highlight the importance of research in improving patient outcomes.